{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:11:03Z","timestamp":1790655063375,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12029-020-00397-w","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T02:02:38Z","timestamp":1584496958000},"page":"256-262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Treatment Modality and Trends in Survival for Gallbladder Cancer: a Population-Based Study"],"prefix":"10.1007","volume":"52","author":[{"given":"Noori","family":"Akhtar-Danesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gileh-Gol","family":"Akhtar-Danseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Shakeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Finley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"issue":"6","key":"397_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3322\/canjclin.51.6.349","volume":"51","author":"EC Lazcano-Ponce","year":"2001","unstructured":"Lazcano-Ponce EC, Miquel JF, Munoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51(6):349\u201364.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"397_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/1097-0142(197807)42:1<330::AID-CNCR2820420150>3.0.CO;2-F","volume":"42","author":"MD Perpetuo","year":"1978","unstructured":"Perpetuo MD, Valdivieso M, Heilbrun LK, Nelson RS, Connor T, Bodey GP. Natural history study of gallbladder cancer: a review of 36 years experience at M. D. Anderson Hospital and Tumor Institute. Cancer. 1978;42(1):330\u20135.","journal-title":"Cancer."},{"key":"397_CR3","unstructured":"Cancer Research UK. Gallbladder Cancer (C23-C24): 2009\u20132013. Cancer Research UK;2016."},{"issue":"7","key":"397_CR4","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/ijc.21683","volume":"118","author":"G Randi","year":"2006","unstructured":"Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118(7):1591\u2013602.","journal-title":"Int J Cancer"},{"issue":"3","key":"397_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF01229532","volume":"119","author":"W Zatonski","year":"1993","unstructured":"Zatonski W, La Vecchia C, Levi F, Negri E, Lucchini F. Descriptive epidemiology of gall-bladder cancer in Europe. J Cancer Res Clin Oncol. 1993;119(3):165\u201371.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"397_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","volume":"4","author":"S Misra","year":"2003","unstructured":"Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4(3):167\u201376.","journal-title":"Lancet Oncol"},{"issue":"8","key":"397_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/jso.20536","volume":"93","author":"R Steinert","year":"2006","unstructured":"Steinert R, Nestler G, Sagynaliev E, Muller J, Lippert H, Reymond MA. Laparoscopic cholecystectomy and gallbladder cancer. J Surg Oncol. 2006;93(8):682\u20139.","journal-title":"J Surg Oncol"},{"issue":"8","key":"397_CR8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/hpb.12444","volume":"17","author":"TA Aloia","year":"2015","unstructured":"Aloia TA, Jarufe N, Javle M, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17(8):681\u201390.","journal-title":"HPB (Oxford)"},{"issue":"3","key":"397_CR9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s12029-017-9940-y","volume":"49","author":"SK Singh","year":"2018","unstructured":"Singh SK, Talwar R, Kannan N, Tyagi AK, Jaiswal P, Kumar A. Patterns of presentation, treatment, and survival rates of gallbladder cancer: a prospective study at a tertiary care centre. J Gastrointest Cancer. 2018;49(3):268\u201374.","journal-title":"J Gastrointest Cancer"},{"issue":"8","key":"397_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jso.20538","volume":"93","author":"X de Aretxabala","year":"2006","unstructured":"de Aretxabala X, Roa I, Berrios M, Hepp J, Gallardo J, Cordova A, et al. Chemoradiotherapy in gallbladder cancer. J Surg Oncol. 2006;93(8):699\u2013704.","journal-title":"J Surg Oncol"},{"issue":"4","key":"397_CR11","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/cam4.1044","volume":"6","author":"R Rahman","year":"2017","unstructured":"Rahman R, Simoes EJ, Schmaltz C, Jackson CS, Ibdah JA. Trend analysis and survival of primary gallbladder cancer in the United States: a 1973-2009 population-based study. Cancer Med. 2017;6(4):874\u201380.","journal-title":"Cancer Med"},{"issue":"1","key":"397_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jso.21544","volume":"102","author":"SY Cho","year":"2010","unstructured":"Cho SY, Kim SH, Park SJ, et al. Adjuvant chemoradiation therapy in gallbladder cancer. J Surg Oncol. 2010;102(1):87\u201393.","journal-title":"J Surg Oncol"},{"issue":"11","key":"397_CR13","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1080\/0284186X.2018.1478124","volume":"57","author":"P Lindner","year":"2018","unstructured":"Lindner P, Holmberg E, Hafstrom L. Gallbladder cancer - no improvement in survival over time in a Swedish population. Acta Oncol. 2018;57(11):1482\u20139.","journal-title":"Acta Oncol"},{"issue":"2","key":"397_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000336217","volume":"29","author":"CDM Witjes","year":"2012","unstructured":"Witjes CDM, van den Akker SAW, Visser O, Karim-Kos HE, de Vries E, Ijzermans JN, et al. Gallbladder cancer in the Netherlands: incidence, treatment and survival patterns since 1989. Dig Surg. 2012;29(2):92\u20138.","journal-title":"Dig Surg"},{"issue":"2","key":"397_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.amjsurg.2017.02.006","volume":"214","author":"PK Mishra","year":"2017","unstructured":"Mishra PK, Saluja SS, Prithiviraj N, Varshney V, Goel N, Patil N. Predictors of curative resection and long term survival of gallbladder cancer - a retrospective analysis. Am J Surg. 2017;214(2):278\u201386.","journal-title":"Am J Surg"},{"key":"397_CR16","unstructured":"Statistics Canada. Table 98\u2013402- X2016001: Populaiton and dwelling counts, Census year 2006. 2017 2017."},{"issue":"17","key":"397_CR17","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1002\/cncr.25427","volume":"116","author":"CM Booth","year":"2010","unstructured":"Booth CM, Li G, Zhang-Salomons J, Mackillop WJ. The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada. Cancer. 2010;116(17):4160\u20137.","journal-title":"Cancer"},{"issue":"2","key":"397_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3747\/co.22.2359","volume":"22","author":"OM Ginsburg","year":"2015","unstructured":"Ginsburg OM, Fischer HD, Shah BR, et al. A population-based study of ethnicity and breast cancer stage at diagnosis in Ontario. Curr Oncol. 2015;22(2):97\u2013104.","journal-title":"Curr Oncol"},{"issue":"2","key":"397_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/1536867X0900900206","volume":"9","author":"PC Lambert","year":"2009","unstructured":"Lambert PC, Royston P. Further development of flexible parametric models for survival analysis. Stata J. 2009;9(2):265\u201390.","journal-title":"Stata J"},{"issue":"15","key":"397_CR20","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/sim.1203","volume":"21","author":"P Royston","year":"2002","unstructured":"Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002;21(15):2175\u201397.","journal-title":"Stat Med"},{"issue":"1","key":"397_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canep.2011.05.010","volume":"36","author":"MJ Rutherford","year":"2012","unstructured":"Rutherford MJ, Dickman PW, Lambert PC. Comparison of methods for calculating relative survival in population-based studies. Cancer Epidemiol. 2012;36(1):16\u201321.","journal-title":"Cancer Epidemiol"},{"issue":"8","key":"397_CR22","first-page":"485","volume":"110","author":"I Justo","year":"2018","unstructured":"Justo I, Marcacuzco A, Nutu OA, Manrique A, Calvo J, Caso \u00d3, et al. A retrospective analysis of patients with gallbladder cancer: surgical treatment and survival according to tumor stage. Rev Esp Enferm Dig. 2018;110(8):485\u201392.","journal-title":"Rev Esp Enferm Dig"},{"issue":"2","key":"397_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11894-006-0013-9","volume":"8","author":"HA Pitt","year":"2006","unstructured":"Pitt HA, Nakeeb A. Operative approach to gallbladder cancer. Curr Gastroenterol Rep. 2006;8(2):161\u20137.","journal-title":"Curr Gastroenterol Rep"},{"issue":"4","key":"397_CR24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1067\/msy.2002.127555","volume":"132","author":"A Nakeeb","year":"2002","unstructured":"Nakeeb A, Tran KQ, Black MJ, et al. Improved survival in resected biliary malignancies. Surgery. 2002;132(4):555\u201363 discission 563\u2013554.","journal-title":"Surgery"},{"issue":"2","key":"397_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.gtc.2010.02.011","volume":"39","author":"GD Eslick","year":"2010","unstructured":"Eslick GD. Epidemiology of gallbladder cancer. Gastroenterol Clin N Am. 2010;39(2):307\u201330 ix.","journal-title":"Gastroenterol Clin N Am"},{"issue":"2","key":"397_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","volume":"15","author":"AX Zhu","year":"2010","unstructured":"Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist. 2010;15(2):168\u201381.","journal-title":"Oncologist."},{"issue":"1","key":"397_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1245\/s10434-017-6139-1","volume":"25","author":"BH Kim","year":"2018","unstructured":"Kim BH, Kwon J, Chie EK, Kim K, Kim YH, Seo DW, et al. Adjuvant chemoradiotherapy is associated with improved survival for patients with resected gallbladder carcinoma: a systematic review and meta-analysis. Ann Surg Oncol. 2018;25(1):255\u201364.","journal-title":"Ann Surg Oncol"},{"issue":"30","key":"397_CR28","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1200\/JCO.2010.29.3605","volume":"28","author":"A Sharma","year":"2010","unstructured":"Sharma A, Dwary AD, Mohanti BK, Deo SV, Pal S, Sreenivas V, et al. Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. J Clin Oncol. 2010;28(30):4581\u20136.","journal-title":"J Clin Oncol"},{"issue":"8","key":"397_CR29","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/sj.bjc.6601736","volume":"90","author":"DC Doval","year":"2004","unstructured":"Doval DC, Sekhon JS, Gupta SK, Fuloria J, Shukla VK, Gupta S, et al. A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer. 2004;90(8):1516\u201320.","journal-title":"Br J Cancer"},{"issue":"10","key":"397_CR30","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1023\/A:1012543223020","volume":"12","author":"JO Gallardo","year":"2001","unstructured":"Gallardo JO, Rubio B, Fodor M, Orlandi L, Y\u00e1\u00f1ez M, Gamargo C, et al. A phase II study of gemcitabine in gallbladder carcinoma. Ann Oncol. 2001;12(10):1403\u20136.","journal-title":"Ann Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00397-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-020-00397-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00397-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T13:09:21Z","timestamp":1628600961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-020-00397-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1007\/s12029-020-00397-w","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"18 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The local institutional ethics board reviewed and approved the research proposal for this retrospective study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data and\/or information compiled and provided by CIHI. However, the analyses, conclusions, opinions, and statements expressed in the material are those of the authors and not necessarily those of CIHI. Also, parts of this material are based on data and information provided by Cancer Care Ontario (CCO). The opinions, results, view, and conclusions reported in this paper are those of the authors and do not necessarily reflect those of CCO. No endorsement by CCO is intended or should be inferred.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}